When it comes to her feelings about investing in care delivery startups, it's a real "mixed bag" for Ulili Onovakpuri, managing partner at Kapor Capital. This is because a lot of them operate on a cash-pay model. She summarized the issue quite succinctly: there's an incredible amount of innovation happening, but the people who could benefit the most from this type of care will be the last ones to receive it.
Don't miss the first forum highlighting the key approaches to leveraging scalable, secure and compliant cloud technologies within drug discovery and clinical research – discover more in the agenda.
INVEST 2023 will unite innovative startups, active investors as well as forward-thinking healthcare providers, payers and life science companies. Join us for exclusive networking opportunities and engaging content that highlights the opportunities and challenges the industry faces as it continues to evolve.
By Frank Vinluan Wednesday, November 16, 2022 3:07 AM
Cell and gene therapies are offering patients potentially curative treatments for a growing scope of diseases. Insurance companies are trying to figure out how to pay for them. Industry consultants speaking at the HLTH conference offered some strategies they see payers taking to these new therapies.
By Amanda James Tuesday, November 15, 2022 5:35 PM
Judge Robert McBurney of Fulton County said sections of the Living Infants Fairness and Equality Act passed in 2019 were unconstitutional when drafted and enacted, therefore there is "no legal basis" for the ban which has banned abortion after six weeks.
By Adam Sinensky Tuesday, November 15, 2022 1:45 PM
As the industry strives for data use that is standardized, consistent, and fluid, payers that automate data flow, in the long run, will be able to discern the risk of each member and prioritize their needs to drive member services for outcomes-based care delivery.
By Joyce Gomes-Osman Tuesday, November 15, 2022 1:00 PM
Ideally, novel therapeutics will be introduced in combination with lifestyle interventions that are going to need to be personalized to each individual, and anchored in reliable, longitudinal metrics to enable modifications as needed.
By Frank Czerwiec Tuesday, November 15, 2022 9:30 AM
Seventy-four years ago, patients received hope for a medical miracle. Despite the disappointments which have accompanied that hope, steroids continue to play an important role in the treatment of debilitating symptoms of many autoimmune and other conditions. Now, equipped with decades of advances in our understanding of human biology, the time has come to innovate and execute on that promise.
By Yang Yang and Daniel Millard Tuesday, November 15, 2022 9:10 AM
Opioids are our most effective tool for treating pain, but what if there were a better way to stop pain without relying on addictive substances? To develop a non-addictive painkiller, scientists have been searching for proteins that appear on pain neurons but not in the reward pathway, and this has been no small task.
By Marissa Plescia Tuesday, November 15, 2022 8:30 AM
The new solution is called Quantum Health Access, which offers healthcare benefits navigation, provider search, claims assistance, point solution referral and member engagement communications.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments